FiASP vs. aspart using an advanced closed-loop system

Not Applicable

Active, not recruiting

• Conditions: type 1 diabetes; Metabolic and Endocrine - Diabetes

• Registration Number: ACTRN12619000469112
• Lead Sponsor: Medtronic Diabetes

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-03-21
• Last Update Posted: 23 March 2020

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

Type 1 diabetes of >1 year duration
Stable on insulin pump therapy for >3 months
Proficient in carbohydrate counting
Continuous glucose monitoring (CGM) sensor experience
HbA1c <10.0%

Exclusion Criteria

Pregnancy
eGFR <40ml/min/1.73m2
History of diabetic ketoacidosis or severe hypoglycaemia in the last 3 months
Diabetic gastroparesis

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Time spent with sensor glucose 3.9–10.0 mmol/L using uploaded CGM data[1) Final 6 weeks of Stage 1 and Stage 2<br>2) During and 4 hours post-meal interventions eg. late meal-bolus; missed meal-bolus (specific to a particular intervention and aggregated)<br>]